Potent Drug Product Filler Suite

SSOE supported a new pharmaceutical client in renovating approximately 7,000 SF of existing space at its Midwest facility to accommodate production of a new product. The fast-track project converted a former storage area, an inactive production space, and an unfinished area into production-ready suites designed to support new equipment and operational requirements. The renovation required extensive technical coordination to create a compliant potent powder processing environment within an active pharmaceutical manufacturing facility. SSOE’s design addressed open powder operations at CNC-plus containment levels and incorporated personnel and material airlocks, mist showers, low-wall returns, bag-in / bag-out housings, and other containment features to support safe and efficient production.

A primary challenge was adapting three distinct existing conditions into pharmaceutical-grade manufacturing spaces while minimizing disruption to ongoing operations. The team reconfigured the existing rooms to meet cleanroom and production requirements, and evaluated and repurposed an existing air-handling unit, along with energy recovery equipment, to support the new suites. The system was designed to provide 10 air changes per hour while maintaining GMP-focused temperature, humidity, and airflow performance.

To accelerate implementation, SSOE maximized the use of existing infrastructure wherever possible. The team coordinated phased demolition; relocated compressed air and nitrogen systems; and designed new mechanical, electrical, plumbing, fire protection, lighting, data, fire alarm, security, and controlled-access systems. Design development continued in parallel with equipment planning, accommodating owner-furnished equipment not yet on site.

By organizing the work into phased bid and construction packages, SSOE accelerated project delivery, enabling the client to move quickly from concept development to permit-ready documentation. Commissioning is expected in November 2026, with operations expected to begin in December 2026.